PER 1.27% 8.0¢ percheron therapeutics limited

Diamond’s last day at ANP, page-32

  1. 13,729 Posts.
    lightbulb Created with Sketch. 1461
    Oh Oh !

    Ask yourself why is Platinum ( Biotech Fund ) still a major shareholder in Anp if Atl1102 is not compelling and you don’t think much of the Science:?
    Tell me . Sarepta and another 3 Pharmas involved in DMD ( none of them can offer a cure) All these 4 Pharmas will need Anp ( Atl1102)for combination therapy.
    There is no drug for Limb Girdle
    Atl1102 could be the first to treat LG .
    Thank you for acknowledging that it’s the market that is destroying shareholder wealth.
    There will be many mining stocks that won’t survive : Raising $$$ very difficult .


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.